Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A study using data from the China Kadoorie Biobank study (CKB) and led by researchers from Oxford Population Health and Peking University has found that gout is linked to increased risk of several diseases.

Patients in China are waiting outside

Gout is the most common form of inflammatory arthritis. The study, published today in The Lancet Regional Health – Western Pacific, provides a comprehensive assessment of the distribution pattern of gout and hyperuricemia (the sustained elevated blood urate level, a measure of the amount of uric acid in the blood and a precursor of gout) and their relationships with a range of other diseases in a Chinese population. The findings may inform prevention and management approaches in China and globally.

The researchers analysed data from 0.5 million CKB participants recruited between 2004 and 2008 from ten diverse urban and rural areas in China. All participants had comprehensive baseline self-reported information on lifestyle risk factors and medical history and were followed up for 12 years with linked electronic health records, with 16,800 participants also having blood plasma urate level measured.

The researchers examined how common gout and hyperuricemia were in difference socio-demographic subgroups, and then looked at the relationships between gout and 16 major conditions and death from all causes.

 

Read the full story on the Nuffield Department of Population Health website.

Similar stories

First clinical study in GSK-Oxford Experimental Medicine Collaboration starts as first patient dosed in ulcerative colitis experimental trial

The first patient in the PEGASUS clinical study, part of the GSK-University of Oxford Experimental Medicine Collaboration, received the first dose last week, on 8 October 2026.

Wearable chest patch could support hospital-level care at home, study finds

Researchers in Oxford have shown that wearable chest patches can be used to effectively monitor vital signs in many acutely unwell patients receiving hospital-level care in their own homes.

Brain immune cells protect neurons in Parkinson’s disease by “nibbling” harmful material

New research, published in Science Translational Medicine, reveals how a specialised population of the brain’s immune cells can remove harmful protein clumps from nerve cells (neurons), pointing to potential new treatments for Parkinson’s disease.

Phase I clinical study of ChAdOx1 BDBV vaccine launches in Uganda

The Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM Uganda Research Unit) has launched a Phase I clinical study evaluating the safety and immunogenicity of a candidate vaccine against Bundibugyo virus disease (BVD), a severe form of Ebola virus disease caused by Bundibugyo virus (BDBV), in partnership with the University of Oxford.

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.